List of Tables
Table 1. Global Organ Transplant Immunosuppressant Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Organ Transplant Immunosuppressant Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Organ Transplant Immunosuppressant Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Organ Transplant Immunosuppressant Sales by Region (2020-2025) & (K Units)
Table 5. Global Organ Transplant Immunosuppressant Sales Forecast by Region (2026-2031) & (K Units)
Table 6. Global Organ Transplant Immunosuppressant Revenue by Region (2020-2025) & (US$ Million)
Table 7. Global Organ Transplant Immunosuppressant Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 8. Global Organ Transplant Immunosuppressant Sales Volume by Type (2020-2025) & (K Units)
Table 9. Global Organ Transplant Immunosuppressant Sales Volume by Type (2026-2031) & (K Units)
Table 10. Global Organ Transplant Immunosuppressant Revenue by Type (2020-2025) & (US$ Million)
Table 11. Global Organ Transplant Immunosuppressant Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 12. Global Organ Transplant Immunosuppressant Sales Volume by Application (2020-2025) & (K Units)
Table 13. Global Organ Transplant Immunosuppressant Sales Volume by Application (2026-2031) & (K Units)
Table 14. Global Organ Transplant Immunosuppressant Revenue by Application (2020-2025) & (US$ Million)
Table 15. Global Organ Transplant Immunosuppressant Revenue by Application (2026-2031) & (US$ Million)
Table 16. Global Organ Transplant Immunosuppressant Sales by Manufacturer (2020-2025) & (K Units)
Table 17. Global Organ Transplant Immunosuppressant Sales Share by Manufacturer (2020-2025)
Table 18. Organ Transplant Immunosuppressant Revenue by Manufacturer (2020-2025) & (US$ Million)
Table 19. Organ Transplant Immunosuppressant Revenue Share by Manufacturer (2020-2025)
Table 20. Key Manufacturers Organ Transplant Immunosuppressant Price (2020-2025) & (US$/Unit)
Table 21. Ranking of Global Top Organ Transplant Immunosuppressant Manufacturers by Revenue (US$ Million) in 2024
Table 22. Global Organ Transplant Immunosuppressant Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 23. Global Organ Transplant Immunosuppressant by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppressant as of 2024)
Table 24. Organ Transplant Immunosuppressant Manufacturers Manufacturing Base Distribution and Headquarters
Table 25. Date of International Manufacturers Enter into Organ Transplant Immunosuppressant Market
Table 26. Manufacturers Organ Transplant Immunosuppressant Product Type and Application
Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 28. Roche Company Information
Table 29. Roche Description and Business Overview
Table 30. Roche Organ Transplant Immunosuppressant Product
Table 31. Roche Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 32. Roche Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 33. Roche Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 34. Roche Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 35. Roche Recent Developments
Table 36. Astellas Pharma Inc. Company Information
Table 37. Astellas Pharma Inc. Description and Business Overview
Table 38. Astellas Pharma Inc. Organ Transplant Immunosuppressant Product
Table 39. Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 40. Astellas Pharma Inc. Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 41. Astellas Pharma Inc. Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 42. Astellas Pharma Inc. Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 43. Astellas Pharma Inc. Recent Developments
Table 44. Huadong Pharmaceutical Company Information
Table 45. Huadong Pharmaceutical Description and Business Overview
Table 46. Huadong Pharmaceutical Organ Transplant Immunosuppressant Product
Table 47. Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 48. Huadong Pharmaceutical Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 49. Huadong Pharmaceutical Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 50. Huadong Pharmaceutical Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 51. Huadong Pharmaceutical Recent Developments
Table 52. Novartis Company Information
Table 53. Novartis Description and Business Overview
Table 54. Novartis Organ Transplant Immunosuppressant Product
Table 55. Novartis Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 56. Novartis Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 57. Novartis Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 58. Novartis Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 59. Novartis Recent Developments
Table 60. Catalent Pharma Company Information
Table 61. Catalent Pharma Description and Business Overview
Table 62. Catalent Pharma Organ Transplant Immunosuppressant Product
Table 63. Catalent Pharma Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 64. Catalent Pharma Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 65. Catalent Pharma Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 66. Catalent Pharma Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 67. Catalent Pharma Recent Developments
Table 68. Cinkate Corporation Company Information
Table 69. Cinkate Corporation Description and Business Overview
Table 70. Cinkate Corporation Organ Transplant Immunosuppressant Product
Table 71. Cinkate Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Cinkate Corporation Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 73. Cinkate Corporation Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 74. Cinkate Corporation Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 75. Cinkate Corporation Recent Developments
Table 76. Cilag Company Information
Table 77. Cilag Description and Business Overview
Table 78. Cilag Organ Transplant Immunosuppressant Product
Table 79. Cilag Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Cilag Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 81. Cilag Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 82. Cilag Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 83. Cilag Recent Developments
Table 84. Genzyme Company Information
Table 85. Genzyme Description and Business Overview
Table 86. Genzyme Organ Transplant Immunosuppressant Product
Table 87. Genzyme Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Genzyme Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 89. Genzyme Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 90. Genzyme Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 91. Genzyme Recent Developments
Table 92. Changzhou Pharm Company Information
Table 93. Changzhou Pharm Description and Business Overview
Table 94. Changzhou Pharm Organ Transplant Immunosuppressant Product
Table 95. Changzhou Pharm Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 96. Changzhou Pharm Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 97. Changzhou Pharm Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 98. Changzhou Pharm Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 99. Changzhou Pharm Recent Developments
Table 100. North China Pharmaceutical Group Corporation Company Information
Table 101. North China Pharmaceutical Group Corporation Description and Business Overview
Table 102. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product
Table 103. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 104. North China Pharmaceutical Group Corporation Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 105. North China Pharmaceutical Group Corporation Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 106. North China Pharmaceutical Group Corporation Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 107. North China Pharmaceutical Group Corporation Recent Developments
Table 108. SL PHARM Company Information
Table 109. SL PHARM Description and Business Overview
Table 110. SL PHARM Organ Transplant Immunosuppressant Product
Table 111. SL PHARM Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 112. SL PHARM Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 113. SL PHARM Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 114. SL PHARM Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 115. SL PHARM Recent Developments
Table 116. Livzon Pharmaceutical Group Inc., Company Information
Table 117. Livzon Pharmaceutical Group Inc., Description and Business Overview
Table 118. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product
Table 119. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 120. Livzon Pharmaceutical Group Inc., Sales Proportion of Organ Transplant Immunosuppressant by Product in 2024
Table 121. Livzon Pharmaceutical Group Inc., Sales Proportion of Organ Transplant Immunosuppressant by Application in 2024
Table 122. Livzon Pharmaceutical Group Inc., Sales Proportion of Organ Transplant Immunosuppressant by Geographic Area in 2024
Table 123. Livzon Pharmaceutical Group Inc., Recent Developments
Table 124. North America Organ Transplant Immunosuppressant Sales by Country (2020-2025) & (K Units)
Table 125. North America Organ Transplant Immunosuppressant Sales by Country (2026-2031) & (K Units)
Table 126. North America Organ Transplant Immunosuppressant Revenue by Country (2020-2025) & (US$ Million)
Table 127. North America Organ Transplant Immunosuppressant Revenue by Country (2026-2031) & (US$ Million)
Table 128. North America Organ Transplant Immunosuppressant Sales by Type (2020-2025) & (K Units)
Table 129. North America Organ Transplant Immunosuppressant Sales by Application (2020-2025) & (K Units)
Table 130. Asia-Pacific Organ Transplant Immunosuppressant Sales by Region (2020-2025) & (K Units)
Table 131. Asia-Pacific Organ Transplant Immunosuppressant Sales by Region (2026-2031) & (K Units)
Table 132. Asia-Pacific Organ Transplant Immunosuppressant Revenue by Region (2020-2025) & (US$ Million)
Table 133. Asia-Pacific Organ Transplant Immunosuppressant Revenue by Region (2026-2031) & (US$ Million)
Table 134. Asia-Pacific Organ Transplant Immunosuppressant Sales by Type (2020-2025) & (K Units)
Table 135. Asia-Pacific Organ Transplant Immunosuppressant Sales by Application (2020-2025) & (K Units)
Table 136. Europe Organ Transplant Immunosuppressant Sales by Country (2020-2025) & (K Units)
Table 137. Europe Organ Transplant Immunosuppressant Sales by Country (2026-2031) & (K Units)
Table 138. Europe Organ Transplant Immunosuppressant Revenue by Country (2020-2025) & (US$ Million)
Table 139. Europe Organ Transplant Immunosuppressant Revenue by Country (2026-2031) & (US$ Million)
Table 140. Europe Organ Transplant Immunosuppressant Sales by Type (2020-2025) & (K Units)
Table 141. Europe Organ Transplant Immunosuppressant Sales by Application (2020-2025) & (K Units)
Table 142. Latin America Organ Transplant Immunosuppressant Sales by Country (2020-2025) & (K Units)
Table 143. Latin America Organ Transplant Immunosuppressant Sales by Country (2026-2031) & (K Units)
Table 144. Latin America Organ Transplant Immunosuppressant Revenue by Country (2020-2025) & (US$ Million)
Table 145. Latin America Organ Transplant Immunosuppressant Revenue by Country (2026-2031) & (US$ Million)
Table 146. Latin America Organ Transplant Immunosuppressant Sales by Type (2020-2025) & (K Units)
Table 147. Latin America Organ Transplant Immunosuppressant Sales by Application (2020-2025) & (K Units)
Table 148. Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2020-2025) & (K Units)
Table 149. Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2026-2031) & (K Units)
Table 150. Middle East and Africa Organ Transplant Immunosuppressant Revenue by Country (2020-2025) & (US$ Million)
Table 151. Middle East and Africa Organ Transplant Immunosuppressant Revenue by Country (2026-2031) & (US$ Million)
Table 152. Middle East and Africa Organ Transplant Immunosuppressant Sales by Type (2020-2025) & (K Units)
Table 153. Middle East and Africa Organ Transplant Immunosuppressant Sales by Application (2020-2025) & (K Units)
Table 154. Organ Transplant Immunosuppressant Key Raw Materials, Industry Status and Trend
Table 155. Organ Transplant Immunosuppressant Key Raw Materials and Upstream Suppliers
Table 156. Organ Transplant Immunosuppressant Clients Status and Trend
Table 157. Organ Transplant Immunosuppressant Typical Clients
Table 158. Organ Transplant Immunosuppressant Distributors
Table 159. Organ Transplant Immunosuppressant Market Trends
Table 160. Organ Transplant Immunosuppressant Market Drivers
Table 161. Organ Transplant Immunosuppressant Market Challenges
Table 162. Organ Transplant Immunosuppressant Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
Table 166. QYR Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Organ Transplant Immunosuppressant Product Picture
Figure 2. Global Organ Transplant Immunosuppressant Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Organ Transplant Immunosuppressant Sales Market Share by Type in 2024 & 2031
Figure 4. Tacrolimus Product Picture
Figure 5. Mycophenolate Mofetil Product Picture
Figure 6. Cyclosporin Product Picture
Figure 7. Others Product Picture
Figure 8. Global Organ Transplant Immunosuppressant Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Organ Transplant Immunosuppressant Sales Market Share by Application in 2024 & 2031
Figure 10. Liver Transplant
Figure 11. Kidney Transplant
Figure 12. Heart Transplant
Figure 13. Other Organ Transplant
Figure 14. Organ Transplant Immunosuppressant Report Years Considered
Figure 15. Global Organ Transplant Immunosuppressant Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Organ Transplant Immunosuppressant Market Size 2020-2031 (US$ Million)
Figure 17. Global Organ Transplant Immunosuppressant Sales 2020-2031 (K Units)
Figure 18. Global Organ Transplant Immunosuppressant Sales Market Share Forecast by Region (2020-2031)
Figure 19. Global Organ Transplant Immunosuppressant Revenue Market Share by Region (2020-2031)
Figure 20. Global Organ Transplant Immunosuppressant Sales Market Share Forecast by Type (2020-2031)
Figure 21. Global Organ Transplant Immunosuppressant Revenue Market Share Forecast by Type (2020-2031)
Figure 22. Organ Transplant Immunosuppressant Average Selling Price (ASP) by Type (2020-2025) & (US$/Unit)
Figure 23. Global Organ Transplant Immunosuppressant Sales Market Share Forecast by Application (2020-2031)
Figure 24. Global Organ Transplant Immunosuppressant Revenue Market Share Forecast by Application (2020-2031)
Figure 25. Organ Transplant Immunosuppressant Average Selling Price (ASP) by Application (2020-2025) & (US$/Unit)
Figure 26. Tacrolimus of Organ Transplant Immunosuppressant Revenue Market Share by Application, 2024 VS 2031
Figure 27. Mycophenolate Mofetil of Organ Transplant Immunosuppressant Revenue Market Share by Application, 2024 VS 2031
Figure 28. Cyclosporin of Organ Transplant Immunosuppressant Revenue Market Share by Application, 2024 VS 2031
Figure 29. Others of Organ Transplant Immunosuppressant Revenue Market Share by Application, 2024 VS 2031
Figure 30. Global Organ Transplant Immunosuppressant Sales Share by Manufacturer in 2024
Figure 31. Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 32. Tacrolimus Market Sales Proportion by Manufacturer in 2024
Figure 33. Mycophenolate Mofetil Market Sales Proportion by Manufacturer in 2024
Figure 34. Cyclosporin Market Sales Proportion by Manufacturer in 2024
Figure 35. Others Market Sales Proportion by Manufacturer in 2024
Figure 36. North America Organ Transplant Immunosuppressant Revenue 2020-2031 (US$ Million)
Figure 37. North America Organ Transplant Immunosuppressant Sales Market Share by Type (2020-2025)
Figure 38. North America Organ Transplant Immunosuppressant Sales Market Share by Application (2020-2025)
Figure 39. Asia-Pacific Organ Transplant Immunosuppressant Revenue 2020-2031 (US$ Million)
Figure 40. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share by Region (2020-2031)
Figure 41. Asia-Pacific Organ Transplant Immunosuppressant Revenue Market Share by Region (2020-2031)
Figure 42. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share by Type (2020-2025)
Figure 43. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share by Application (2020-2025)
Figure 44. Europe Organ Transplant Immunosuppressant Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Europe Organ Transplant Immunosuppressant Sales Market Share by Country (2020-2031)
Figure 46. Europe Organ Transplant Immunosuppressant Revenue Market Share by Country (2020-2031)
Figure 47. Europe Organ Transplant Immunosuppressant Sales Market Share by Type (2020-2025)
Figure 48. Europe Organ Transplant Immunosuppressant Sales Market Share by Application (2020-2025)
Figure 49. Latin America Organ Transplant Immunosuppressant Revenue Growth Rate 2020-2031 (US$ Million)
Figure 50. Latin America Organ Transplant Immunosuppressant Sales Market Share by Country (2020-2031)
Figure 51. Latin America Organ Transplant Immunosuppressant Revenue Market Share by Country (2020-2025)
Figure 52. Latin America Organ Transplant Immunosuppressant Sales Market Share by Type (2020-2025)
Figure 53. Latin America Organ Transplant Immunosuppressant Sales Market Share by Application (2020-2025)
Figure 54. Middle East and Africa Organ Transplant Immunosuppressant Revenue Growth Rate 2020-2031 (US$ Million)
Figure 55. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share by Country (2020-2031)
Figure 56. Middle East and Africa Organ Transplant Immunosuppressant Revenue Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share by Type (2020-2025)
Figure 58. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share by Application (2020-2025)
Figure 59. Organ Transplant Immunosuppressant Supply Chain (Upstream and Downstream Market)
Figure 60. Global Production Market Share of Organ Transplant Immunosuppressant Raw Materials by Region in 2024
Figure 61. Organ Transplant Immunosuppressant Distribution Channels
Figure 62. Global Organ Transplant Immunosuppressant Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 63. Global Organ Transplant Immunosuppressant Percentage 2020-2031: Online Sales VS Offline Sales
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
